Replies to post #213086 on Biotech Values

[DewDiligence]

RVNC latest slide set (8/10/17):

http://investors.revance.com/common/download/download.cfm?companyid=AMDA-2GNRV0&fileid=953583&filekey=52A8D2C5-7900-4F55-8595-1EA8C217BABE&filename=Revance_Company_Presentation_Update_8_10_17.pdf

[kris_kade]

Thanks again. CC starting at 7:30 mark clearly mentions both safety & composite PE&SE for Sakura 1&2 will be reported in 4Q. So agree we can expect a single PR.